Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in Pediatric CKD
NCT01020487Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Feb 2010
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by AbbVie Inc.. Started Feb 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01020487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020487.